Search Results - "Ahmed, Syed O."
-
1
FLT3 inhibitors for treating Acute Myeloid Leukemia
Published in Clinical lymphoma, myeloma and leukemia (01-10-2016)“…FLT3 (Fms-like tyrosine kinase 3) inhibitors are tyrosine kinase inhibitors. The first-generation FLT3 inhibitors were developed several years ago and include…”
Get full text
Journal Article -
2
Comprehensive Genomic Analysis of Noonan Syndrome and Acute Myeloid Leukemia in Adults: A Review and Future Directions
Published in Acta haematologica (2020)“…Acute myeloid leukemia (AML) in the setting of Noonan syndrome (NS) has been reported before without clear guidelines for treatment or prognosis in these…”
Get more information
Journal Article -
3
A postal survey of doctors' attitudes to becoming mentally ill
Published in Clinical medicine (London, England) (01-08-2009)“…A postal survey of 3,512 doctors in Birmingham was carried out to assess attitudes to becoming mentally ill. The response rate for the questionnaire was 70%…”
Get full text
Journal Article -
4
Role of gene therapy in Fanconi anemia: A systematic and literature review with future directions
Published in Hematology/oncology and stem cell therapy (01-12-2021)“…Gene therapy (GT) has been reported to improve bone marrow function in individuals with Fanconi anemia (FA); however, its clinical application is still in the…”
Get full text
Journal Article -
5
Special report: Summary of the first meeting of African Blood and Marrow Transplantation (AfBMT) group, Casablanca, Morocco, April 19–21, 2018 held under the auspices of the Worldwide Network for Blood and Marrow Transplantation (WBMT)
Published in Hematology/oncology and stem cell therapy (01-12-2020)“…The first meeting of the African Blood and Marrow Transplantation (AfBMT) was held in Casablanca from April 19, 2018 to April 21, 2018, with the aim of…”
Get full text
Journal Article -
6
Hematopoietic stem cell transplantation in Saudi Arabia between 1984 and 2016: Experience from four leading tertiary care hematopoietic stem cell transplantation centers
Published in Hematology/oncology and stem cell therapy (01-09-2021)“…Saudi Arabia is the largest of the Arabian Gulf countries with a total population of 33.41 million as of 2017. This report summarizes the experience from four…”
Get full text
Journal Article -
7
THPO–MPL pathway and bone marrow failure
Published in Hematology/oncology and stem cell therapy (01-03-2015)“…Abstract Single or multilineage bone marrow failure can be a serious health problem caused by hereditary and non-hereditary causes such as exposure to drugs or…”
Get full text
Journal Article -
8
Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations
Published in Biology of blood and marrow transplantation (01-12-2019)“…The development of hematopoietic stem cell transplantation (HSCT) programs can face significant challenges in most developing countries because such endeavors…”
Get full text
Journal Article -
9
-
10
Allogeneic Hematopoietic Stem Cell Transplantation in Adolescent and Adult Patients with High-Risk T Cell Acute Lymphoblastic Leukemia
Published in Biology of blood and marrow transplantation (01-12-2012)“…Allogeneic hematopoietic stem cell transplantation (allo-SCT) is often recommended for patients with T cell acute lymphoblastic leukemia (T-ALL) in second or…”
Get full text
Journal Article -
11
Fertility Recovery Following Allogeneic Bone Marrow Transplantation in Aplastic Anemia; A Study of 157 Patients
Published in Biology of blood and marrow transplantation (01-03-2016)Get full text
Journal Article -
12
Pre-Conditioning Steroids and Hydroxyurea Followed By Reduced Toxicity Conditioning (RTC) with ATG-Bu-FLU Is Safe and Effective in Allo-Sib-HSCT in Adolescents and Adults with Sickle Cell Anemia (SCA)
Published in Biology of blood and marrow transplantation (01-02-2015)Get full text
Journal Article -
13
Allogeneic Hematopoietic Cell Transplant Yields Long Term Disease Free Survival in a Significant Number of Patients with Classic Hodgkin Lymphoma
Published in Blood (15-11-2022)Get full text
Journal Article -
14
-
15
Clinical Characterization, Cancer Incidence and Long-Term Outcomes of Fanconi Anemia Patients : A Single Center Analysis of 97 Patients
Published in Blood (15-11-2022)Get full text
Journal Article -
16
Sequential Fludarabine, Ara-C, Etoposide (FLAV) Followed By Fludarabine/ Busulfan Reduced Toxicity Conditioning Is Safe and Effective Salvage for Adult Patients with Refractory Acute Myeloid Leukemia and High Risk Myelodysplasia
Published in Blood (23-11-2021)“…Background A significant proportion of patients with acute myeloid leukemia (AML) will either be refractory to initial chemotherapy or will suffer refractory…”
Get full text
Journal Article -
17
Trends of Hematopoietic Stem Cell Transplantation in the Eastern Mediterranean Region, 1984-2007
Published in Biology of blood and marrow transplantation (01-09-2011)“…Hematopoietic stem cell transplantation (HSCT) activity was surveyed in the 9 countries in the World Health Organization Eastern Mediterranean region that…”
Get full text
Journal Article -
18
Excellent Outcomes Using a Non-Myeloablative Conditioning with Thiotepa and Post -Transplant Cyclophosphamide in Adults Undergoing a Matched Related Donor Bone Marrow Transplant for Severe Sickle Cell Disease
Published in Transplantation and cellular therapy (01-02-2024)“…Allogeneic hematopoietic stem-cell transplantation (HSCT) is a validated curative therapy for sickle cell disease (SCD). The excellent outcomes of matched…”
Get full text
Journal Article -
19
The Outcome of Tisagenlecleucel (Tisa-Cel) Vs Axicabtagene Ciloleucel (Axi-Cel) CD-19 CAR-T Cell Therapy in Relapsed/Refractory NHL: Real World Data from a Single Institution Experience
Published in Transplantation and cellular therapy (01-02-2024)“…Non-Hodgkin lymphoma (NHL) in Saudi Arabia exhibits an incidence rate of 6.1%, with estimated age adjusted incidence is 6/100,000, presenting at an advanced…”
Get full text
Journal Article -
20
Favorable Outcomes in Severe Aplastic Anemia Patients Undergoing Allo-HSCT with Fludarabine, Cyclophosphamide, and ATG Conditioning
Published in Transplantation and cellular therapy (01-02-2024)“…Matched sibling donor (MSD) allogenic stem cell transplantation (allo-HSCT) is the standard of care curative treatment for young, fit patients with severe…”
Get full text
Journal Article